JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug

Haematologica. 2013 Nov;98(11):e135-7. doi: 10.3324/haematol.2013.087742.
No abstract available

Keywords: AML/MDS; PV; busulfan; polycythemia vera.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles*
  • Busulfan / therapeutic use*
  • Female
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Myeloablative Agonists / therapeutic use*
  • Polycythemia Vera / drug therapy*
  • Polycythemia Vera / genetics*

Substances

  • Myeloablative Agonists
  • JAK2 protein, human
  • Janus Kinase 2
  • Busulfan